Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Nicotine and endogenous opioids: neurochemical and pharmacological evidence.

Authors:
Maria Hadjiconstantinou Norton H Neff

Neuropharmacology 2011 Jun 22;60(7-8):1209-20. Epub 2010 Nov 22.

Department of Psychiatry, Division of Molecular Neuropsychopharmacology, The Ohio State University, College of Medicine, Columbus, OH 43210, USA.

Although the mesolimbic dopamine hypothesis is the most influential theory of nicotine reward and reinforcement, there has been a consensus that other neurotransmitter systems contribute to the addictive properties of nicotine as well. In this regard, the brain opioidergic system is of interest. Striatum is rich in opioid peptides and opioid receptors, and striatal opioidergic neurons are engaged in a bidirectional communication with midbrain dopaminergic neurons, closely regulating each other's activity. Enkephalins and dynorphins exert opposing actions on dopaminergic neurons, increasing and decreasing dopamine release respectively, and are components of circuits promoting positive or negative motivational and affective states. Moreover, dopamine controls the synthesis of striatal enkephalins and dynorphins. Evidence suggests that opioidergic function is altered after nicotine and endogenous opioids are involved in nicotine's behavioral effects. 1) The synthesis and release of β-endorphin, met-enkephalin and dynorphin in brain, especially nucleus accumbens (NAc), are altered after acute or chronic nicotine treatment and during nicotine withdrawal. 2) Although opioid receptor binding and mRNA do not appear to change in the striatum during nicotine withdrawal, the activity of κ-opioid (KOPr) and δ-opioid (DOPr) receptors is attenuated in NAc. 3) The nicotine withdrawal syndrome reminisces that of opiates, and naloxone precipitates some of its somatic, motivational, and affective signs. 4) Genetic and pharmacological studies indicate that μ-opioid (MOPr) receptors are mainly involved in nicotine reward, while DOPrs contribute to the emotional and KOPrs to the aversive responses of nicotine. 5) Finally, MOPrs and enkephalin, but not β-endorphin or dynorphin, are necessary for the physical manifestations of nicotine withdrawal. This article is part of a Special Issue entitled 'Trends in neuropharmacology: in memory of Erminio Costa'.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neuropharm.2010.11.010DOI Listing
June 2011

Publication Analysis

Top Keywords

nicotine withdrawal
16
nicotine
11
nicotine reward
8
enkephalins dynorphins
8
dopaminergic neurons
8
motivational affective
8
nicotine endogenous
8
endogenous opioids
8
nucleus accumbens
4
altered acute
4
acute chronic
4
nac altered
4
β-endorphin met-enkephalin
4
accumbens nac
4
met-enkephalin dynorphin
4
brain nucleus
4
dynorphin brain
4
treatment nicotine
4
mrna appear
4
appear change
4

Altmetric Statistics


Show full details
2 Total Shares
2 Wikipedia Pages
2 Citations

Similar Publications

Early life adversity and appetite hormones: The effects of smoking status, nicotine withdrawal, and relapse on ghrelin and peptide YY during smoking cessation.

Authors:
Mustafa al'Absi Briana DeAngelis Motohiro Nakajima Dorothy Hatsukami Sharon Allen

Addict Behav 2021 Feb 8;118:106866. Epub 2021 Feb 8.

Department of Family Medicine and Community Health, University of Minnesota, Twin Cities, Minneapolis, MN, USA.

There is evidence suggesting that ghrelin and peptide YY (PYY) modulate stress responses and the rewarding effects of drugs, although no research has examined the impact of exposure to early life stress on these hormones in smokers nor during smoking cessation. This study examined the relationships between early life adversity (ELA) and circulating ghrelin and PYY during ad libitum smoking and early withdrawal in tobacco smokers (N = 98) who were interested in cessation. We also included a comparison group of nonsmokers (N = 36). Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Female rats display greater nicotine withdrawal-induced cellular activation of a central portion of the interpeduncular nucleus versus males: A study of Fos immunoreactivity within provisionally assigned interpeduncular subnuclei.

Authors:
Felix Matos-Ocasio Veronika E Espinoza Paola Correa-Alfonzo Arshad M Khan Laura E O'Dell

Drug Alcohol Depend 2021 Feb 16;221:108640. Epub 2021 Feb 16.

Department of Psychology, The University of Texas at El Paso, El Paso, TX, USA. Electronic address:

Background: The interpeduncular nucleus (>1840) (IPN) has been shown to modulate the behavioral effects of nicotine withdrawal in male rodents. To date, the contribution of this brain structure to sex differences in withdrawal is largely unexplored.

Methods: This study compared neuronal activation, as reported by observable Fos expression in the IPN of nicotine-dependent female and male rats experiencing withdrawal. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Sex differences in circulating inflammatory mediators as a function of substance use disorder.

Authors:
April C May Kaiping Burrows Leandra K Figueroa-Hall Namik Kirlic Evan J White Ryan Smith Hamed Ekhtiari Martin P Paulus Jonathan Savitz Jennifer L Stewart

Drug Alcohol Depend 2021 Feb 15;221:108610. Epub 2021 Feb 15.

Laureate Institute for Brain Research, Tulsa, OK, USA; Oxley College of Health Sciences, The University of Tulsa, Tulsa, OK, USA.

Background: Substance use disorders (SUD) with comorbid depression and anxiety are linked to poor treatment outcome and relapse. Although some depressed individuals exhibit elevated blood-based inflammation (interleukin-6 [IL-6] and C reactive protein [CRP]), few studies have examined whether the presence of SUD exacerbates inflammation.

Methods: Treatment-seeking individuals with major depressive disorder (MDD), anxiety disorders, and/or SUD (N = 160; 80 % with MDD) recruited into the Tulsa 1000 study provided blood samples, participated in clinical interviews, and completed a questionnaire battery querying symptoms of current psychopathology and emotional processing. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Tobacco cigarette smokers who endorse greater intolerance for nicotine withdrawal also report more severe insomnia symptoms.

Authors:
Emma C Lape Lisa R LaRowe Emily L Zale Les A Gellis Aesoon Park Joseph W Ditre

Exp Clin Psychopharmacol 2021 Feb 25. Epub 2021 Feb 25.

Department of Psychology.

It has been suggested that nighttime nicotine withdrawal may help to explain why tobacco cigarette smokers are more likely than nonsmokers to experience clinically significant insomnia. There is also reason to believe that intolerance for withdrawal symptoms could play a role in withdrawal-related sleep disturbance. However, we are not aware of any previous research that examined whether smokers who endorse greater intolerance for smoking abstinence also report greater difficulty initiating and/or maintaining sleep. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Smoking cessation in individuals who use vaping as compared with traditional nicotine replacement therapies: a systematic review and meta-analysis.

Authors:
Catherine M Pound Jennifer Zhe Zhang Ama Tweneboa Kodua Margaret Sampson

BMJ Open 2021 Feb 22;11(2):e044222. Epub 2021 Feb 22.

Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada.

Objectives: Despite the aggressive marketing of electronic nicotine device systems (ENDS) as smoking cessation tools, the evidence of their effectiveness is mixed. We conducted a systematic review of randomised controlled trials to determine the effect of ENDS on cigarette smoking cessation, as compared with other types of nicotine replacement therapies (NRT).

Design: Systematic review and meta-analysis using the Grading of Recommendations Assessment, Development and Evaluation approach. Read More

View Article and Full-Text PDF
February 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap